ACDF Using Structural Allograft vs. Tritanium C

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

About this trial

This is an observational, descriptive, prospective and retrospective data collection study. The purpose of this study is to observe radiographic outcomes of patients who will undergo anterior cervical discectomy and fusion (ACDF) utilizing Tritanium C (Stryker Spine). The rate of fusion success and adverse events will be compared retrospectively to patients who underwent instrumented ACDF utilizing structural allograft bone with plates.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Males or females ≥18 years of age, ≤ 80 years of age

Subject is skeletally mature

Subject is diagnosed with degenerative disc disease (DDD) at one level or two contiguous levels from the C2 -T1 disc

Subject has received six weeks of non-operative therapy i.e. injections, physical therapy, oral steroids

Disqualifiers

Presence of an infection systemic or local

Presence of marked local inflammation

Subject has any abnormality present which affects the normal process of bone remodeling including, but not limited to, severe osteoporosis involving the spine, bone absorption, osteopenia, primary or metastatic tumors involving the spine, active infection at the site or certain metabolic disorders affecting osteogenesis

Use of bone growth stimulator

Trial design

Design model

Parallel

Treatments tested in this trial

  • Structural allograft

    Procedure/Surgery

    Subjects that have received ACDF structural allograft with plates with autograft and/or allograft comprised of cancellous and/or corticocancellous bone chips

  • Tritanium C

    Device

    Subjects will receive the Tritanium C anterior cervical cage which is intended to be used with autogenous or allogenic bone graft comprised of cancellous and/or corticocancellous bone graft

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: RetrospectiveActive comparator 1 intervention
Group B: ProspectiveExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Time to the presence of fusion

Antero-posterior and lateral plain radiographs

Time frame
3 months post-operatively
2

Time to the presence of fusion

Antero-posterior and lateral plain radiographs

Time frame
6 months post-operatively
3

Time to the presence of fusion

Antero-posterior and lateral plain radiographs

Time frame
12 months post-operatively

Secondary outcomes

1

Neck disability

Neck Disability Index (NDI): Subjects will designate a statement that best describes their level of disability for each section of the survey. Statements are then ranked from 0-5, where 0 is a better outcome and 5 is a worse outcome. All rankings are totaled for a final score.

Time frame
Baseline, 3, 6, and 12 months post-operatively
2

Neck and arm pain

Visual Analog Scale (VAS) for neck and arm pain: Subjects will designate a score to represent their pain from 0 to 10. 0 is indicative of no pain and 10 is indicative of the worst possible pain.

Time frame
Baseline, 3, 6, and 12 months post-operatively
3

Incidence of sensory deficits

Yes or no response to: Sensory deficit at the surgical level, sensory deficit at an adjacent level to the surgical level, sensory deficit at a different level to the surgical level, any sensory deficit during follow-up

Time frame
Baseline, 3, 6, and 12 months post-operatively
4

Incidence of motor deficits

Yes or no response to: Motor deficit at the surgical level, motor deficit at an adjacent level to the surgical level, motor deficit at a different level to the surgical level, any motor deficit

Time frame
Baseline, 3, 6, and 12 months post-operatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.